We are live on ! Find out more
WSA

Wall Street Associates Portfolio holdings

AUM $151M
1-Year Est. Return 30.3%
This Fund
S&P 500
This Quarter Est. Return
+11.73%
1 Year Est. Return
+30.3%
3 Year Est. Return
+94.41%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$250M
AUM Growth
+$9.2M
Cap. Flow
-$4.28M
Cap. Flow %
-1.71%
Top 10 Hldgs %
15.79%
Holding
246
New
29
Increased
25
Reduced
14
Closed
33

Top Buys

Rank Stock Value
1
ARA
American Renal Associates Holdings, Inc
ARA
+$2.69M
2
LGIH icon
LGI Homes
LGIH
+$2.09M
3
ALNT icon
Allient
ALNT
+$2.06M
4
CZR icon
Caesars Entertainment
CZR
+$1.92M
5
STRL icon
Sterling Infrastructure
STRL
+$1.56M

Top Sells

Rank Stock Value
1
SCAI
Surgical Care Affiliates, Inc.
SCAI
+$3.89M
2
MTSI icon
MACOM Technology Solutions
MTSI
+$3.24M
3
SAAS
inContact, Inc.
SAAS
+$2.23M
4
SCOR icon
Comscore
SCOR
+$2.11M
5
RKUS
RUCKUS WIRELESS INC COM STK (DE)
RKUS
+$2.01M

Sector Composition

Rank Sector Weight
1 Technology 28.32%
2 Healthcare 21.29%
3 Consumer Discretionary 15.53%
4 Industrials 12.53%
5 Consumer Staples 4.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARC
76
DELISTED
ARC Document Solutions, Inc.
ARC
$1.32M 0.53%
338,776
-27,924
-8% -$114K
XRN
77
Chiron Real Estate Inc
XRN
$464M
$1.31M 0.53%
+26,000
New +$1.31M
MTLS
78
Materialise
MTLS
$393M
$1.31M 0.52%
182,861
– –
TECH icon
79
Bio-Techne
TECH
$11.2B
$1.24M 0.5%
43,948
+1,080
+3% +$27.8K
BBG
80
DELISTED
Bill Barrett Corp
BBG
$1.22M 0.49%
191,400
– –
ACIA
81
DELISTED
Acacia Communications Inc
ACIA
$1.21M 0.48%
+30,300
New +$1.11M
SEIC icon
82
SEI Investments
SEIC
$12.6B
$1.19M 0.47%
24,663
– –
TMO icon
83
Thermo Fisher Scientific
TMO
$214B
$1.18M 0.47%
8,000
– –
LULU icon
84
lululemon athletica
LULU
$14B
$1.16M 0.47%
15,751
+3,607
+30% +$239K
LRCX icon
85
Lam Research
LRCX
$385B
$1.15M 0.46%
137,000
– –
FRSH
86
DELISTED
Papa Murphy's Holdings, Inc
FRSH
$1.15M 0.46%
173,500
– –
EGLT
87
DELISTED
Egalet Corporation
EGLT
$1.14M 0.45%
228,890
– –
ARGS
88
DELISTED
Argos Therapeutics, Inc.
ARGS
$1.14M 0.45%
9,255
-465
-5% -$62.1K
CBIO
89
Crescent Biopharma
CBIO
$586M
$1.09M 0.44%
1,500
– –
ACTA
90
DELISTED
Actua Corp
ACTA
$1.08M 0.43%
120,200
– –
JBHT icon
91
JB Hunt Transport Services
JBHT
$25.6B
$1.08M 0.43%
13,400
– –
TCON
92
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$1.06M 0.42%
1,208
– –
SGYP
93
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$1.02M 0.41%
269,300
– –
VCYT icon
94
Veracyte
VCYT
$3.71B
$1.01M 0.4%
200,400
– –
RRTS
95
DELISTED
RoadRunner Transportation Systems, Inc.
RRTS
$1M 0.4%
5,380
– –
AVGO icon
96
Broadcom
AVGO
$1.99T
$993K 0.4%
63,910
– –
TVRD
97
Tvardi Therapeutics
TVRD
$18.8M
$925K 0.37%
5,342
– –
CORI
98
DELISTED
Corium International, Inc.
CORI
$922K 0.37%
265,700
– –
AXAS
99
DELISTED
Abraxas Petroleum Corp
AXAS
$904K 0.36%
40,000
– –
LUMO
100
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$890K 0.36%
8,778
– –
2 3
4
5 6

Similar funds

CF
CenterStar Fund Chicago, Illinois $159M AUM 13.43% 1-Year Est. Return
VWM
Vector Wealth Management Minneapolis, Minnesota $142M AUM 10.42% 1-Year Est. Return
HH
H7 Holdings Charlottesville, Virginia $141M AUM
NSCP
Night Square Capital Partners New York $136M AUM
EEG
E.E. Geduld $178M AUM 29.34% 1-Year Est. Return
BC
Bocage Capital San Francisco, California $185M AUM 61.49% 1-Year Est. Return
WRHAM
W.R. Huff Asset Management Stuart, Florida $116M AUM 5.81% 1-Year Est. Return
SRP
Saddle Road Partners Omaha, Nebraska $197M AUM 13.19% 1-Year Est. Return

Wall Street Associates's Q2 2016 Portfolio in Review

As of Q2 2016, Wall Street Associates held 246 positions worth $250M, up 3.8% from $241M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Wall Street Associates's Q2 2016 filing shows 29 new, 25 increased, 14 reduced and 33 closed positions. Its largest new stake was American Renal Associates Holdings, Inc: 96,713 shares worth $2.8M. The largest sale was Surgical Care Affiliates, Inc., an estimated $3.89M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Wall Street Associates's largest Q2 2016 buy was American Renal Associates Holdings, Inc: 96,713 shares worth $2.8M.
  • Wall Street Associates added most to Instructure, Inc. in Q2 2016, an estimated $818K increase.
  • Wall Street Associates's biggest Q2 2016 reduction was Xactly Corporation, cutting an estimated $1.31M.
  • Wall Street Associates fully exited Surgical Care Affiliates, Inc. in Q2 2016, selling an estimated $3.89M.
  • Wall Street Associates's ten largest holdings make up 16% of its $250M portfolio in Q2 2016.
  • Wall Street Associates opened 29 new positions and closed 33 in Q2 2016.
  • Wall Street Associates's portfolio value rose 3.8% quarter-over-quarter to $250M.

Based on Wall Street Associates's 13F filing for Q2 2016, filed 12 Aug 2016.